Mitochondrial function and reactive oxygen species pathways

Mitochondrial function and reactive oxygen species (ROS) pathways represent a broad set of biochemical processes centered on the electron transport chain (ETC) and oxidative phosphorylation (OXPHOS). Mitochondria are the primary site of cellular ATP production, but they also generate ROS as metabolic byproducts, particularly at Complexes I and III. While low levels of ROS act as essential signaling molecules for cell survival and adaptation, excessive production leads to oxidative stress, damaging mitochondrial DNA, proteins, and lipids. This dysfunction is a hallmark of numerous pathologies, including neurodegenerative diseases like Alzheimer's and Parkinson's, where impaired bioenergetics and oxidative damage drive neuronal loss. In cancer, these pathways are often reprogrammed to support rapid proliferation and resist apoptosis, making them attractive targets for 'mitocans'—drugs that disrupt mitochondrial integrity to induce cell death. Therapeutic interventions include mitochondria-targeted antioxidants (e.g., MitoQ, Elamipretide) designed to scavenge ROS at their source and ETC inhibitors (e.g., Metformin) that modulate metabolic flux. However, because these pathways are fundamental to nearly all eukaryotic cells, pharmacological targeting requires high specificity to avoid systemic toxicity and impaired energy metabolism in healthy tissues.

Other names

Mitochondrial respirationOxidative phosphorylation (OXPHOS)Redox signalingMitochondrial bioenergeticsMitochondrial reactive oxygen species (mtROS) pathwaysMitochondrial electron transport chain (ETC) pathways

Modulation of the electron transport chain (ETC) complexes, uncoupling of oxidative phosphorylation, or scavenging of mitochondrial reactive oxygen species (mtROS) to restore redox balance or induce metabolic stress and apoptosis.